The clinical guideline provides evidence-based recommendations for managing Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum. It includes tools like the PUQE and HELP scores to assess severity, recommends first-line antiemetics like Doxylamine and Pyridoxine, and outlines the use of second-line treatments like Ondansetron. The guideline emphasizes the importance of assessing electrolyte levels, using combinations of antiemetics for non-responders, and offering thiamine supplementation. It also addresses the impact of these conditions on mental health, quality of life, and pregnancy outcomes. The guideline aims to guide healthcare professionals in providing comprehensive care for women experiencing severe nausea and vomiting during pregnancy.